NCT05424874 (ExTRACT) is a clinical trial in Acute Kidney Injury, sponsored by AlgoDx.

Who is sponsoring NCT05424874?

NCT05424874 is sponsored by AlgoDx.

What condition does NCT05424874 study?

NCT05424874 studies Acute Kidney Injury.

Is NCT05424874 still recruiting?

NCT05424874 is currently completed. Last updated 13 December 2022.

Last reviewed 2022-12-13 · How we verify

NCT05424874: ExTRACT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Validation of NAVOY® Acute Kidney Injury in Swedish ICU Patients

Completed Last updated 13 December 2022

What this trial tests

trial in Acute Kidney Injury in 304 participants. Completed in 1 November 2021.

Timeline

2 December 2020

Primary endpoint
1 November 2021

1 November 2021

Quick facts

Lead sponsor	AlgoDx
Status	Completed
Study type	OBSERVATIONAL
Enrollment	304
Start date	2 December 2020
Primary completion	1 November 2021
Estimated completion	1 November 2021
Sites	1 location across Sweden

Conditions studied

Acute Kidney Injury — all drugs for Acute Kidney Injury →

Sponsor

AlgoDx

Who can join

18 and older, any sex, with Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to evaluate the performance of the prediction algorithm NAVOY® AKI in a Swedish adult ICU patient population versus fulfilment of KDIGO diagnostic criteria.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Machine Learning Algorithm Predicting Acute Kidney Injury in Intensive Care Unit Patients (NAVOY Acute Kidney Injury): Proof-of-Concept Study.
Persson I, Grünwald A, Morvan L, Becedas D, et al · · 2023 · cited 2× · PMID 38096015 · DOI 10.2196/45979

Verify or expand the search:

Other recruiting trials for Acute Kidney Injury

Currently open trials in the same condition.

NCT07273838 — Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome · Phase 2 · recruiting
NCT07262320 — Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America · recruiting
NCT07351149 — Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery · recruiting
NCT07215702 — A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kid · Phase 2 · recruiting
NCT06654193 — Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury · Phase 1, PHASE2 · recruiting

Other AlgoDx trials

Trials by the same sponsor.

NCT05095220 — Integration of NAVOY® Sepsis in an Electronic Health Record System · completed
NCT04570618 — Early Prediction of Sepsis · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05424874 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by AlgoDx
Last refreshed: 13 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05424874.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing